MSH2

MSH2 Full Name

mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)

MSH2 Introduction

The MSH2 (mutS homolog 2) gene encodes a critical protein responsible for maintaining the fidelity of the human genome during DNA replication. As a foundational component of the DNA mismatch repair (MMR) system, MSH2 acts as the guardian of genetic information, identifying and correcting errors that occur when DNA is copied in preparation for cell division. This gene first garnered significant scientific attention when it was identified as the locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC), now more commonly known as Lynch syndrome. Since its discovery as a human homolog of the bacterial mutS gene, MSH2 has become one of the most clinically important genes in cancer predisposition, serving as a cornerstone for understanding hereditary cancer syndromes and guiding patient management.

Figure 1. Strcuture of MSH2.

Molecular Function in DNA Mismatch Repair
MSH2 serves as the essential recognition subunit of the DNA mismatch repair system, functioning as part of two distinct heterodimeric complexes. It partners with MSH6 to form the MutS alpha complex, which specifically recognizes single base mismatches and small insertion-deletion loops of one or two nucleotides. Alternatively, MSH2 dimerizes with MSH3 to form the MutS beta complex, which recognizes larger insertion-deletion loops of up to 13 nucleotides. This partnership versatility allows the cell to detect and correct a wide spectrum of replication errors. The repair mechanism operates through a sophisticated ATP-dependent molecular switch. When the MSH2-containing complex encounters a DNA mismatch, it undergoes a conformational change that converts it from a static recognition factor into a sliding clamp capable of diffusion along the DNA backbone. This transition is coupled with ADP-to-ATP exchange and positions the complex to recruit downstream repair factors, including the MutL alpha heterodimer (MLH1-PMS2). Together, these proteins coordinate the excision of the damaged DNA strand and its resynthesis using the complementary strand as a template. Beyond its canonical role in post-replicative repair, MSH2 participates in additional genome maintenance functions, including DNA homologous recombination repair, cell cycle checkpoint regulation, and the promotion of apoptosis in response to certain types of DNA damage.

Conclusion
MSH2 stands as a paradigm for how a single gene can bridge fundamental cellular biology, hereditary cancer predisposition, and clinical patient management. As the central recognition subunit of the DNA mismatch repair system, MSH2 safeguards genomic integrity by detecting and initiating repair of replication errors. Germline mutations in this gene produce a spectrum of clinical conditions ranging from adult-onset Lynch syndrome with site-specific cancer risks to the devastating childhood cancer syndrome CMMRD. Emerging research continues to expand our understanding of MSH2 function, revealing unexpected roles in mitochondrial biology and cellular metabolism that may offer new avenues for cancer interception and treatment. From its initial discovery as a bacterial mutS homolog to its current status as one of the most clinically actionable cancer predisposition genes, MSH2 exemplifies the translation of basic scientific discovery into tangible benefits for patient care.

Alternate Names for MSH2

MSH2; mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli); COCA1, mutS (E. coli) homolog 2 (colon cancer, nonpolyposis type 1); DNA mismatch repair protein Msh2; HNPCC; HNPCC1; hMSH2; FCC1; COCA1; LCFS2;